Sole Distributor for GP COVID-19 IgM&IgG Antibody Detection Kit. Manufactured by a leading listed company in its field. A fast screening tool without the need of lab environment or equipments to tell if a person has been infected by coronavirus. It has been tested in clinical trial with excellent outcome. The whole test lasts only 10-15 minutes. Anyone can do it and anyone should do!
SARS-CoV-2 IgM/IgG Antibody Test (Colloidal Gold) Origin: China Certification/Registration: NMPA, CE Specimens: WholeBlood / Serum / Plasma Relative Sensitivity: 88.89% Relative Specificity: 100.00% Accuracy: 91.07% Results in 15 minutes Simultaneous detection of IgM/IgG antibodies thereby minimizing risk of missed detection. No equipment needed, suitable for on-site screening. Package: 25T/box, 1000T/CTN CTN Size: 60*40*37 cm G.W./N.W.: 13/12 kgs
USA: FDA EUA APPROVED Approved for Import to European Union Approved by Chinese Government (CFDA) for Export Qualitative detection of the presence of IgM & IgG antibody to COVID-19 in Human serum, plasma and whole blood Results available in 10 minutes Component: Cassette, Sample Diluent, Pipette and Test Card
Intended Use Novel Coronavirus (2019-nCoV) Real-time RT-PCR Kit is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the 2019-nCoV in oropharyngeal swabs and bronchoalveolar lavage fluid collected form individuals suspected of COVID-19 by their healthcare provider. About SARS-CoV-2 Specific antibodies will be produced within days to weeks as the immune system makes immune defense against the SARS-CoV-2 infection. Total antibody detection is an aid in the diagnosis of patients with suspected SARS-CoV-2 infection in conjunction with clinical symptoms and result of other diagnostic methods. The test result should not be used as the sole basis for diagnosis and exclusion of SARS-CoV-2 infection. Total antibody may not be detected in the first few days of infection. SARS-CoV-2 neutralizing antibody is a protective soluble protein secreted by adaptive immunizing cells after inoculation with SARS-CoV-2 vaccine or infection with SARS-CoV-2. These antibodies can specific bind with virus RNA binding domain (RBD) to block the binding of RBD with angiotensin-converting enzyme 2 (ACE2) on human cells surface, thus prevent the virus or its genetic material into the human cell and virus infection. Benifits of the Kit 1) Room Temperature Transportation 2) Cost-Effective Shipping The shipping is at room temperature, with no need of cold chain shipping. 3) Highly Sensitive, Highly Specific Highly sensitive and highly specific for 2019-nCoV, reliable identification of COVID-19. 4) Environmentally Friendly The kit needs neither bulky packaging nor cold chain shipping. Contents A kit contains: Package specifications: 24 tests/kit, 48 tests/kit 1) 2019-nCoV-PCR Master Mix (Lyophilized Powder): 1 bottle/box 2) 2019-nCoV-PCR Positive Control (Lyophilized Powder):1 bottle/box 3) 2019-nCoV Diluent: 1 bottle/box 4) User Manual Note: Do not mix or interchange different batches of kits.
General Information One-Step Dengue Rapid Test is to detect IgG&IgM antibodies in serum, plasma or whole blood. For Dengue IgG/IgM Ab test: Sensitivity : 99.9% , Specificity : 99.5% Specimen : Serum , Plasma and Whole Blood Reading Time : 10 min
SARS-CoV-19 IgG/IgM test kit (15min showing result) Manufacturer: Guangzhou Wanfo Biotech Co., Ltd. a China listing company Certificates: CE certificate, China NMPA approval (export allowed), no FDA approval The price is $5.5/test (FOB) Max delivered quantity: 100,000/weekly More details please enquire Barry Liu whatsapp: +8617810331113 sample available: 20 test & DHL delivery: $200 Download introductions: https://kdocs.cn/l/sLLC9O6rc
The Herpes Simplex Virus Rapid Test is a rapid qualitative lateral flow test designed for the quantitive detection of IgG antibodies to Herpes Simplex Virus (HSV) in human serum/plasma samples. HSV-1 is usually associated with infection in oropharyngeal area and eyes, while HSV-2 causes mostly genital and neonatal infections (5, 6), however, the tissue specificity is not absolute (7). HSV-2 can be isolated occasionally from the oropharynx and 5-10% of primary genital infections may be caused by HSV-1. Infants infected with HSV appear normal at birth, but almost invariably develop symptoms during the newborn period (5, 8, 9). Neonatal HSV infection may remain localized or become disseminated. Localized infection may involve one or a combination of sites. These are skin, eyes, mouth or the central nervous system. Disseminated infection is manifested by pneumonitis, hepatitis, disseminated intravascular coagulopathy and encephalitis. Of the infants with neonatal HSV, about one half of those surviving will develop severe neurological or ocular sequelae. A number of serological procedures have been developed to detect antibodies to HSV. These include complement fixation, indirect immunofluorescent antibody, plaque neutralization, and ELISA (6, 8, 10). Antibody of the IgG class is produced during the first 2-3 weeks of infection with HSV and exists only transiently in most patients. Serologic procedures, which measure the presence of IgG antibodies, help discriminate between primary and recurrent infections, since IgG antibodies is rarely found in recurrent infections. High affinity IgG antibodies to HSV, if present in a sample, may interfere with the detection of IgG specific antibody (9). High affinity IgG antibody may preferentially bind to HSV-1 antigen leading to false negative IgG results. Also, rheumatoid factor, if present, along with antigen specific IgG, may bind to IgG causing false positive IgG results. Both problems can be eliminated by deactivating IgG in the sample before testing for IgG.
Kind : Novel coronavirus pneumonia Standard : Suitable for 2019-nCoV and flu A/B nucleic acid detection Certification : CE Packing : 10 T/box 20 T/box Unit Price ï¼?USDï¼? FOB : 9.12 Aelivery Time : 7Days after signing the contract Yield : 500k per day
Kind : Novel coronavirus pneumonia Standard : Suitable for 2019-nCoV and flu A/B nucleic acid detection Certification : CE Packing : 1;2;10;20;30;40 50ä ;2;10;20;30;40 50 Tests / Kit Unit Price ï¼?USDï¼? FOB : 9.12 Aelivery Time : 7Days after signing the contract 500k per day
Kind :Novel coronavirus pneumonia and flu A/B Nucleid Acid Detection kit Standard : Suitable for 2019-nCoV and flu A/B nucleic acid detection Certification : CE å??è£? Packing : 50 50 Tests / Kit Unit Price FOB : 9.12 Delivery Time : within one week 300k per day
The second brand in the world health organization test list Colloidal Gold Method This kit applies the principle lateral flow chromatographic immunoassay and uses capture method to detect specific IgM and IgG antibodies against novel coronavirus in human specimens (serum, plasma and venous whole blood).
Antibody rapid test kits: Our test kits are superior in sensitivity and specificity. All have CE and FDA registration. Now we are able to offer these same goods and services to your establishment. Delivery 14 days. If you are interested, please do not hesitate to contact us. Thank you for your kind attention. Best regards. Chaveng Munchantip (George) Director (Medical Supplies)
Antibody rapid test kits: Our test kits are also superior in sensitivity and specificity. All have CE and FDA registration. Now we are able to offer these same goods and services to your establishment. Delivery 14 days. If you are interested, please do not hesitate to contact us. Thank you for your kind attention. Best regards. Chaveng Munchantip (George) Director (Medical Supplies)
Assay+ Zika antibody rapid test is manufactured in Canada to detect specific Zika IgG and IgM for the healthcare providers. Assay+ Zika Rapid Test Kit is qualitative test device for Zika IgM/IgG antibodies in human serum, plasma, whole blood or finger tip blood. This device has been used by our end customers with large quantitiy. Sensitivity over 65% for IgM and 85% for IgG and 100% specificity have been proved used by our customers in large quantity.
VETLabs Toxoplasma IgM/IgG test is a sandwich lateral flow immunochromatographic assay, developed and manufactured by Bioguard Corporation, for the rapid and qualitative detection of Toxoplasma IgM/IgG in cat's blood. The test device has a testing window, coated by an invisible T (test) zone and C (control) zone. When a sample is applied to the sample well on the device, the reagent will laterally flow on the surface of the test strip. If there is enough Toxoplasma IgM/IgG in the sample, a visible T band will appear. The C band should always appear after a sample is applied, indicating a valid test. By the means, the device can accurately indicate the presence of Toxoplasma IgM/IgG in the specimen. Kit components: 5 test per box and/or 10 test kit per box in an individual foil pouch with a desiccant and disposable dropper, EDTA blood collection tube, Assay buffer bottle, Instruction manual
The CLIA Waived COVID-19 IgG/IgM Rapid Test Device is an in vitro immunoassay for the direct and qualitative detection of anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG in human whole blood, serum, or plasma. The test is for professional use only. Indication: Qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in human venous whole blood (sodium EDTA), serum, or plasma (sodium EDTA). Intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. Emergency use of this test is limited to authorized laboratories. About Test Device EUA Authorized CE Mark Gives Positive or Negative Result for COVID-19 virus Read Results in 15 Minutes 24 Month Expiration from Date of Manufacture Contents 20 Test Devices 20 Disposable Pipettes 20 Alcohol Prep Pads Sterile Safety Lancets Buffer Package Insert
The FactView Typhoid IgG/IgM Rapid Test Kit is a diagnostic assay used for the qualitative detection of IgG and IgM antibodies specific to Salmonella typhi, the bacterium that causes typhoid fever. Here's more information about this type of diagnostic test: Purpose: The test is used for the rapid diagnosis of typhoid fever, a bacterial infection caused by Salmonella typhi. Typhoid fever is characterized by fever, abdominal pain, headache, and other symptoms, and it can lead to serious complications if not treated promptly. Principle: The FactView Typhoid IgG/IgM Rapid Test Kit is an immunochromatographic assay that detects the presence of IgG and IgM antibodies in a patient's blood sample. IgM antibodies are typically produced during the acute phase of infection, while IgG antibodies are produced later during the convalescent phase. Components: The test kit usually includes test cassettes, sample droppers, buffer solutions, and desiccants. The test cassettes contain pre-coated membranes with specific antigens for capturing IgG and IgM antibodies against Salmonella typhi. Procedure: The test procedure involves collecting a small amount of blood from the patient (usually obtained via finger prick) and applying it to the sample well of the test cassette. Buffer solution is then added, allowing the blood sample to migrate along the test strip. Results are typically visible within 15-20 minutes. Interpretation: The appearance of colored lines on the test strip indicates the presence or absence of IgG and IgM antibodies against Salmonella typhi. A visible line in the control region indicates that the test is valid. Additional lines in the test region(s) indicate positive results for IgG and/or IgM antibodies. Sensitivity and Specificity: The FactView Typhoid IgG/IgM Rapid Test Kit demonstrates sensitivity and specificity for detecting typhoid fever. However, like all diagnostic tests, false-positive and false-negative results are possible and should be interpreted in conjunction with clinical findings. Utility: The rapid detection of IgG and IgM antibodies against Salmonella typhi provides valuable information for diagnosing acute or recent typhoid fever infections, determining immune status, and guiding patient management decisions. Limitations: While rapid diagnostic tests are useful for typhoid fever diagnosis, they have limitations compared to more sensitive methods such as blood culture or molecular testing. Factors such as test sensitivity, specificity, and the timing of specimen collection can influence test performance. Overall, the FactView Typhoid IgG/IgM Rapid Test Kit is an important tool for diagnosing typhoid fever, allowing for timely patient management and implementation of control measures. However, results should be interpreted carefully in conjunction with clinical evaluation and other laboratory tests.
2019-nCoV Neutralizing Antibody Test Kit Fluorescence Immunochromatography (Serum/plasma) Rapid Test: Just for 15 Minutes Accurate Result: Fluorescence immunoassay, high sensitivity Convenient operation with smart POCT analyzers Rate COVID-19 Vaccine immediately Application By testing neutralizing antibody titer after COVID-19 Vaccination, it will be able to figure out the vaccine efficiency Product Information Product Name: 2019-nCoV Neutralizing Antibody Determination Kit Methodology:Fluorescence immunoassay Size:25 Tests/box Storage and Validity:Stored at 2-30 within 18 months Specimen:-Clinical fresh human serum, recommended EDTA anticoagulant plasma Easy Operation: 1 Take 100 sample to buffer and mix 5-10s 2 Add 80 mixed sample to strip 3 Incubation time: 15 mins 4 Put strip into analyzer to test
MOQ - 5,000 Test Price/Unit - US$2.00
1. The One Step RV IgG/IgM Test can be performed used on Whole Blood /Serum / Plasma. 2. To collect whole blood, serum or plasma specimens following regular clinical laboratory procedures. 3. Testing should be performed immediately after specimen collection. Do not leave the specimens at room temperature for prolonged periods. For long term storage, specimens should be kept below -20â??. Whole blood should be stored at 2-8â?? if the test is to be run within 2 days of collection. Do not freeze whole blood specimens. 4. Bring specimens to room temperature prior to testing. Frozen specimens must be completely thawed and mixed well prior to testing. Specimens should not be frozen and thawed repeatedly. Test Procedure Allow the test, specimen, buffer and/or controls to reach room temperature 15-30â?? (59-86â??) prior to testing. 1. Bring the pouch to room temperature before opening it. Remove the test device from the sealed pouch and use it as soon as possible. 2. Place the test device on a clean and level surface. 3. Hold the dropper vertically and transfer 1 drop of specimen (approximately 10μl) to the specimen well(S) of the test device, then add 2 drops of buffer (approximately 80μl) and start the timer. See illustration below. 4. Wait for the colored line(s) to appear. Read results at 15 minutes. Do not interpret the result after 20 minutes. Interpretation of Results Positive: Control line and at least one test line appear on the membrane. The appearance of T2 test line indicates the presence of RV specific IgG antibodies. The appearance of T1 test line indicates the presence of RV specific IgM antibodies. And if both T1 and T2 line appear, it indicates that the presence of both RV specific IgG and IgM antibodies. The lower the antibody concentration is, the weaker the result line is. Negative: One colored line appears in the control region(C). No apparent colored line appear in the test line region. Invalid: Control line fails to appear. Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for control line failure. Review the procedure and repeat the test with a new test device. If the problem persists, discontinue using the test kit immediately and contact your local distributor.
